# Genetic risk classification for adults with AML receiving less-intensive therapies: the 2024 ELN recommendations

*PRI Rank #1 · Topics and Trends in Most Cited Acute Myeloid Leukemia Research Papers, Class of 2026*

*Canonical URL: https://pri.pepkio.com/top-papers/acute-myeloid-leukemia-research/2026/rank-1*

| Field | Value |
| --- | --- |
| Rank | #1 |
| 18m citations | 147 |
| Journal | Blood |
| Year | 2024 |
| DOI | 10.1182/blood.2024025409 |
| Corresponding authors | Hartmut Döhner |
| Institution | Ulm University Hospital, Germany |

**Ranking page:** [Topics and Trends in Most Cited Acute Myeloid Leukemia Research Papers, Class of 2026](https://pri.pepkio.com/top-papers/acute-myeloid-leukemia-research/2026)

**Paper link:** [10.1182/blood.2024025409](https://doi.org/10.1182/blood.2024025409)

## Topics

European LeukemiaNet (ELN) · European LeukemiaNet (ELN) risk classification · Acute myeloid leukemia (AML) · Low-intensity therapy · Intensive chemotherapy · younger adults with AML · 2024 ELN recommendations · Risk stratification · treatment-specific risk assessment

## Cite this ranking

```
Pepkio Research Index (PRI). Topics and Trends in Most Cited Acute Myeloid Leukemia Research Papers, Class of 2026. https://pri.pepkio.com/top-papers/acute-myeloid-leukemia-research/2026. Accessed 2026-07-31.

Zheng Su, Tinsley Li, Thematic Shifts in Early-High-Impact Cancer Genomics and Diagnostics Research: A Bibliometric and Semantic Analysis. bioRxiv 2026.07.04.736459; doi: https://doi.org/10.64898/2026.07.04.736459
```